Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Carvedilol 25 mg tablets
Teva Pharma GmbH
Healthy
2 trials -
Cefzil® 500 mg tablets
Teva Pharma GmbH
Healthy
1 trial -
Cilostazol 100 mg tablets
Teva Pharma GmbH
Healthy
1 trial -
Cilostazol 50 mg Tablets
Teva Pharma GmbH
Healthy
1 trial -
Citarabina Hikma 2 g/20mL Soluzione Iniettabile, Idarubicin Hikma 1 mg/ml Injektionslösung, Cytarabine 100 mg/ml Solution for Injection or Infusion, Cytarabine 100 mg/ml Solution for Injection or Infusion, Daunoblastin® 20 mg Pulver zur Herstellung einer Infusions- oder Injektionslösung, JNJ-75276617, JNJ-75276617 (G022), Venclyxto 100 mg film-coated tablets, Idarubicin, Venclyxto 100 mg film-coated tablets, JNJ-75276617, JNJ-75276617 (G023), Azacitidine, JNJ-75276617, Citarabina Hikma 500mg/5mL Soluzione I
Janssen-Cilag International N.V.
Acute Myeloid Leukemia
1 trial -
Clarithromycin ER 500 mg tablets
Teva Pharma GmbH
Healthy
2 trials -
Comparative Bioavailability of Cabozantinib Film-Coated Tablets in Healthy Participants Under Fasting Conditions
Lacuna Pharma Pty Ltd
No medical condition.
1 trial -
Comparative Bioavailability of Ruxolitinib 20 mg Film-Coated Tablets in Healthy Participants Under Fasting Conditions.
Lacuna Pharma Pty Ltd
No medical condition.
1 trial -
Comparative Pharmacokinetic of S221237 Tablets in Healthy Participants Under Fed Conditions
The George Institute
No medical condition
1 trial -
Daprodustat 2 mg tablet
GlaxoSmithKline
Anaemia
1 trial -
Desmopressin Acetate 0.2 mg Tablets
Teva Pharma GmbH
Healthy
1 trial -
Dexlansoprazole Delayed Release Orally Disintegrating Tablets
Takeda
Bioavailability
1 trial -
EDG-5506 Tablet
Edgewise Therapeutics
Healthy Volunteer
1 trial -
Empagliflozin 10 MG Oral Tablet [Jardiance]
BRIGHT MINDS BIOSCIENCES INC.
Diabetes Mellitus
1 trial -
Evaluating Bioequivalence of a Fixed Dose Combination versus Individual Tablets of Bempedoic Acid / Ezetimibe, and Atorvastatin.
Daiichi Sankyo
No medical condition.
1 trial -
Evaluating Bioequivalence of a Fixed Dose Combination versus Individual Tablets of Bempedoic Acid, Ezetimibe, and Atorvastatin.
Daiichi Sankyo
No medical condition.
1 trial -
Evaluating Bioequivalence of a Fixed Dose Combination versus Individual Tablets of Bempedoic Acid, Ezetimibe, and Rosuvastatin.
Daiichi Sankyo
No medical condition
1 trial -
Evaluating Bioequivalence of a Fixed Dose Combination versus Tablets of Bempedoic Acid / Ezetimibe and Rosuvastatin.
Daiichi Sankyo
No medical condition.
1 trial -
Evaluation of bioequivalence of two products containing 400 mg ibuprofen and 100 mg caffeine: Ibuprofen / Caffeine 400 mg / 100 mg coated granules (Test) vs. Thomapyrin TENSION DUO, 400mg / 100mg Filmtabletten (Reference). A monocentric, open, randomized, single dose, two-period, crossover trial in healthy volunteers
Lacuna Pharma Pty Ltd
No therapeutic indication in the current trial with healthy volunteers.
1 trial -
Evaluation of bioequivalence of two products containing 600 mg ibuprofen: Ibuprofen Sopharma 600 mg film-coated tablets (Test) vs. Brufen 600 mg film-coated tablets (Comparator). A monocentric, open, randomized, single dose, two-period, crossover trial in healthy volunteers
Lacuna Pharma Pty Ltd
No therapeutic indication in the current trial with healthy volunteers.
1 trial -
Exploratory Bioavailability of Three Formulations of Gliclazide MR Tablets 120 mg (I.R.I.S.) in Healthy Volunteers Under Fed Conditions (High Fat High Calorie Meal and Standard Meal).
The George Institute
No medical condicion.
1 trial -
FAVICOVIR 200 mg Film Tablet
BRIGHT MINDS BIOSCIENCES INC.
Bioequivalence
1 trial -
Famciclovir 500 mg Tablets
Teva Pharma GmbH
Healthy
2 trials -
Fexofenadine 180 mg tablets
Teva Pharma GmbH
Healthy
2 trials
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources